Pharmaceuticals, Biotechnology and Life Sciences
DUBLIN–(BUSINESS WIRE)–The “Exosome Therapeutics Market – Global Industry Size, Share, Trends, Opportunity, & Forecast, 2020-2030” has been added to ResearchAndMarkets.com’s…
Mission Bio’s Tapestri® Platform and custom assay development platform supported exploratory biomarker analysis for Incyte’s INCA033989 clinical trial for myeloproliferative…
DUBLIN–(BUSINESS WIRE)–The “Human Leukocyte Antigen (HLA) Targeted Therapy, Clinical Trials, Therapeutic Approaches & Market Opportunity Insight 2026” report has been…
– The sunbird αSyn™ assay accurately classified Parkinson’s disease-positive blood samples with 81% accuracy through the direct detection of EV-bound…
OXTEND-03™ (NCT06930625) is a Phase III, multi-center, randomized trial assessing the efficacy and safety of Debio 4126, the first and…
An independent Data Safety Monitoring Board (DSMB) confirms EB103’s favorable safety profile with no treatment-related serious adverse events (SAEs) even…
Offering includes Animal Origin-Free Preps, Transfection-Grade Preps and Target Yield with turnaround time starting at four business days for Express…
Management to meet with investors and potential partners during Biotech Showcase 2026 CAMBRIDGE, Mass.–(BUSINESS WIRE)–Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or…
New fixation method streamlines blood sample handling for translational research SEATTLE–(BUSINESS WIRE)–Parse Biosciences, a leading provider of accessible and scalable…
CARMEL, Ind. & LONDON–(BUSINESS WIRE)–#TYK2—Sudo Biosciences, (“Sudo”), a biopharmaceutical company committed to designing and developing best-in-class precision TYK2 (tyrosine kinase…